Search Videos and More
Showing 1 - 6 of 6 results
News
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.
News
Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.
News
The Hoofbeats You Hear May Be a Zebra: Cancer Diagnoses in Ages 18 to 39
At Fox Chase, the Young Adult Cancer Program has been developed as a comprehensive, robust resource to help young adults and their doctors face the challenges of cancer just as someone begins to navigate life’s milestones—finishing school, beginning careers, attaining financial stability, and starting families. It’s a clinical and a psychosocial maelstrom.
Video
The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases
In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases.
Video
Updates: Colon Cancer Screening
This short video, brought to you by Minhhuyen T. Nguyen, MD, AGAF, FACP, Professor in the Department of Medicine and Director of Clinical Gastroenterology at Fox Chase, discusses what's new in colorectal cancer screening—from lowering the age of screening, to the efficacy of screening tests, to new techniques to improve colonoscopy.
News
International Collaboration Finds Ripretinib Significantly Improves Survival for Patients With Advanced Gastrointestinal Stromal Tumors
Researchers at Fox Chase Cancer Center recently published the results of an international study showing improved survival for patients with advanced gastrointestinal stromal tumors who used ripretinib (Qinlock) when compared with patients taking a placebo.